Global Blood Glucose Monitoring Devices Market Professional Survey Report 2019

SKU ID : QYR-14741501 | Publishing Date : 24-Sep-2019 | No. of pages : 108

The global BGM devices market is growing due to the increase in the number of people with diabetes, especially type 1 diabetes. To avoid high doses of medication and insulin intake, these people are moving toward monitoring blood glucose levels by learning about the technicalities and the usage of BGM devices.
Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
North America and Europe are anticipated to lead the global market on account of their large population plagued with diabetes, the region’s rapidly increasing geriatric and obese population, and their high per capita expenditures on healthcare. The Asia Pacific market is expected to rise at a substantial rate during the forecast period ascribed to the populous nations of India and China. The market in Latin America and Middle East & Africa is likely to expand at moderate growth rate over the period of forecast.

The global Blood Glucose Monitoring Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood Glucose Monitoring Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Glucose Monitoring Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Glucose Monitoring Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Glucose Monitoring Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Terumo Corporation
Acon Laboratories
Roche Diagnostics
Johnson&Johnson
ARKRAY
Novo Nordisk
Medtronic
Abbott Laboratories
Ypsomed
Sanofi

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Self-Monitoring Devices
Continuous Glucose Monitoring Devices

Segment by Application
Hospitals and Diagnostic Laboratories
POL
Home-Care Settings

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
3500
7000

5250


  • market Reports market Reports